Clinical trials recruiting for Arrhythmogenic Right Ventricular Cardiomyopathy
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| TN-401 | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| California | 2 |
| Colorado | 2 |
| Maryland | 2 |
| Massachusetts | 2 |
| Minnesota | 2 |
| New York | 2 |
| Ohio | 2 |
| Indiana | 1 |
| South Carolina | 1 |
Top cities
Self-screener
Recruiting trials
- Non-interventional Study of Seroprevalence of Pre-existing Antibodies Against Adenovirus-associated Virus Vector (AAV9) and the Progression of Disease in Patients With Plakophilin 2 (PKP2)-Associated Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)
- Open-label, Dose Escalation Study of Safety and Preliminary Efficacy of TN-401 in Adults With PKP2 Mutation-associated ARVC
- Pediatric Cardiomyopathy Mutation Analysis
Related conditions
Trials recruiting for Arrhythmogenic Right Ventricular Cardiomyopathy often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Arrhythmogenic Right Ventricular Cardiomyopathy trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.